Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Pockets $34M in Fourth VC Financing Round

NEW YORK (GenomeWeb News) — Agendia yesterday said that it has raised €25 million ($34 million) in a fourth financing round.
 
Bank-insurer ING becomes a shareholder, though Agendia would not disclose the amount it invested. However, Agendia called it a “powerful and substantial shareholder.”
 
Also participating in the round were current investors Van Herk Biotech, Gilde Healthcare Partners, and Gobal Life Science Ventures.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.